3-D scaffold has immuno-oncology potential; Harvard team takes on obesity;

> Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard's School of Engineering and Applied Sciences developed a 3-D scaffold that could be used to amp up an immune system attack on cancers or infectious diseases. Release

> Harvard Stem Cell Institute's Chad Cowan and his team members at Harvard University and Massachusetts General Hospital say they have "created a system using human stem cells to screen for compounds that have the potential to turn white, or "bad," fat cells into brown, or "good," fat cells, and have already identified two compounds that can accomplish that in human cells." Release

> Eli Lilly ($LLY) says additional analysis of late-stage data from its failed solanezumab program underscores that functional improvements seen in patients are a consequence of cognitive improvements, making functional endpoints a better secondary endpoint to primary endpoints on cognition. It should be noted that followup analysis of data from failed drug studies offer an imperfect look at a treatment effect on a disease. Release

> There's some preliminary evidence that sleep disturbance could be linked to amyloid accumulation, offering a possible early intervention in preventing Alzheimer's. Release

Suggested Articles

Astellas’ Xospata and Novartis’ Rydapt may help treat lung cancer that has grown resistant to EGFR inhibitors, researchers discovered.

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.